News
Despite resilient demand, healthcare has taken a hit along with the rest of the market. Amgen could boost profits ...
To find out first-hand how pharma tackles safety and pharmacovigilance, we speak with Alan Morrison, who is Amgen's Vice President of Global Regulatory Affairs and Safety.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results